aluates Reports

$ 0.0

Automative

Global Oral Peptide Drugs Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-20L18604

Global Oral Peptide Drugs Market Research Report 2024

BUY CHAPTERS

Global Oral Peptide Drugs Market Research Report 2026

Code: QYRE-Auto-20L18604

Report

2026-02-06

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Novartis

Aurinia

Merck

Oral Peptide Drugs Market

The global Oral Peptide Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Peptide Drugs are usually composed of amino acid chains and can be linear or cyclic structures. Due to their large molecules, peptide drugs are usually administered by injection. Oral peptide drugs refer to peptide drugs that can be administered orally and play an important role in some diseases that require precise regulation of physiological processes.

The North American market for Oral Peptide Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Oral Peptide Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Oral Peptide Drugs in Tumors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Oral Peptide Drugs include Roche, Novartis, Aurinia, Merck & Co, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Oral Peptide Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Peptide Drugs. The Oral Peptide Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oral Peptide Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oral Peptide Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oral Peptide Drugs Market Report

Report Metric	Details
Report Name	Oral Peptide Drugs Market
Segment by Type	Cyclic Peptides Linear Peptides
Segment by Application	Tumors Kidney Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Novartis, Aurinia, Merck & Co
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oral Peptide Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Peptide Drugs Market report?

Ans: The main players in the Oral Peptide Drugs Market are Roche, Novartis, Aurinia, Merck & Co

What are the Application segmentation covered in the Oral Peptide Drugs Market report?

Ans: The Applications covered in the Oral Peptide Drugs Market report are Tumors, Kidney Disease, Other

What are the Type segmentation covered in the Oral Peptide Drugs Market report?

Ans: The Types covered in the Oral Peptide Drugs Market report are Cyclic Peptides, Linear Peptides

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Peptide Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cyclic Peptides

1.2.3 Linear Peptides

1.3 Market by Application

1.3.1 Global Oral Peptide Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Tumors

1.3.3 Kidney Disease

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Peptide Drugs Market Perspective (2021–2032)

2.2 Global Oral Peptide Drugs Growth Trends by Region

2.2.1 Global Oral Peptide Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Oral Peptide Drugs Historic Market Size by Region (2021–2026)

2.2.3 Oral Peptide Drugs Forecasted Market Size by Region (2027–2032)

2.3 Oral Peptide Drugs Market Dynamics

2.3.1 Oral Peptide Drugs Industry Trends

2.3.2 Oral Peptide Drugs Market Drivers

2.3.3 Oral Peptide Drugs Market Challenges

2.3.4 Oral Peptide Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Peptide Drugs Players by Revenue

3.1.1 Global Top Oral Peptide Drugs Players by Revenue (2021–2026)

3.1.2 Global Oral Peptide Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Oral Peptide Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Oral Peptide Drugs Revenue

3.4 Global Oral Peptide Drugs Market Concentration Ratio

3.4.1 Global Oral Peptide Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Peptide Drugs Revenue in 2025

3.5 Global Key Players of Oral Peptide Drugs Head Offices and Areas Served

3.6 Global Key Players of Oral Peptide Drugs, Products and Applications

3.7 Global Key Players of Oral Peptide Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Oral Peptide Drugs Breakdown Data by Type

4.1 Global Oral Peptide Drugs Historic Market Size by Type (2021–2026)

4.2 Global Oral Peptide Drugs Forecasted Market Size by Type (2027–2032)

5 Oral Peptide Drugs Breakdown Data by Application

5.1 Global Oral Peptide Drugs Historic Market Size by Application (2021–2026)

5.2 Global Oral Peptide Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Oral Peptide Drugs Market Size (2021–2032)

6.2 North America Oral Peptide Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Oral Peptide Drugs Market Size by Country (2021–2026)

6.4 North America Oral Peptide Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Peptide Drugs Market Size (2021–2032)

7.2 Europe Oral Peptide Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Oral Peptide Drugs Market Size by Country (2021–2026)

7.4 Europe Oral Peptide Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Oral Peptide Drugs Market Size (2021–2032)

8.2 Asia-Pacific Oral Peptide Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Oral Peptide Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Oral Peptide Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Oral Peptide Drugs Market Size (2021–2032)

9.2 Latin America Oral Peptide Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Oral Peptide Drugs Market Size by Country (2021–2026)

9.4 Latin America Oral Peptide Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Peptide Drugs Market Size (2021–2032)

10.2 Middle East & Africa Oral Peptide Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Oral Peptide Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Oral Peptide Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Oral Peptide Drugs Introduction

11.1.4 Roche Revenue in Oral Peptide Drugs Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Oral Peptide Drugs Introduction

11.2.4 Novartis Revenue in Oral Peptide Drugs Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Aurinia

11.3.1 Aurinia Company Details

11.3.2 Aurinia Business Overview

11.3.3 Aurinia Oral Peptide Drugs Introduction

11.3.4 Aurinia Revenue in Oral Peptide Drugs Business (2021–2026)

11.3.5 Aurinia Recent Development

11.4 Merck & Co

11.4.1 Merck & Co Company Details

11.4.2 Merck & Co Business Overview

11.4.3 Merck & Co Oral Peptide Drugs Introduction

11.4.4 Merck & Co Revenue in Oral Peptide Drugs Business (2021–2026)

11.4.5 Merck & Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Novartis

Aurinia

Merck

List of Tables

Table 1. Global Oral Peptide Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cyclic Peptides

Table 3. Key Players of Linear Peptides

Table 4. Global Oral Peptide Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Oral Peptide Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Oral Peptide Drugs Market Size by Region (US$ Million), 2021–2026

Table 7. Global Oral Peptide Drugs Market Share by Region (2021–2026)

Table 8. Global Oral Peptide Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Oral Peptide Drugs Market Share by Region (2027–2032)

Table 10. Oral Peptide Drugs Market Trends

Table 11. Oral Peptide Drugs Market Drivers

Table 12. Oral Peptide Drugs Market Challenges

Table 13. Oral Peptide Drugs Market Restraints

Table 14. Global Oral Peptide Drugs Revenue by Players (US$ Million), 2021–2026

Table 15. Global Oral Peptide Drugs Market Share by Players (2021–2026)

Table 16. Global Top Oral Peptide Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oral Peptide Drugs Revenue, 2025

Table 17. Ranking of Global Top Oral Peptide Drugs Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Oral Peptide Drugs Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Oral Peptide Drugs, Headquarters and Area Served

Table 20. Global Key Players of Oral Peptide Drugs, Products and Applications

Table 21. Global Key Players of Oral Peptide Drugs, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Oral Peptide Drugs Market Size by Type (US$ Million), 2021–2026

Table 24. Global Oral Peptide Drugs Revenue Market Share by Type (2021–2026)

Table 25. Global Oral Peptide Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Oral Peptide Drugs Revenue Market Share by Type (2027–2032)

Table 27. Global Oral Peptide Drugs Market Size by Application (US$ Million), 2021–2026

Table 28. Global Oral Peptide Drugs Revenue Market Share by Application (2021–2026)

Table 29. Global Oral Peptide Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Oral Peptide Drugs Revenue Market Share by Application (2027–2032)

Table 31. North America Oral Peptide Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Oral Peptide Drugs Market Size by Country (US$ Million), 2021–2026

Table 33. North America Oral Peptide Drugs Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Oral Peptide Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Oral Peptide Drugs Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Oral Peptide Drugs Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Oral Peptide Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Oral Peptide Drugs Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Oral Peptide Drugs Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Oral Peptide Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Oral Peptide Drugs Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Oral Peptide Drugs Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Oral Peptide Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Oral Peptide Drugs Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Oral Peptide Drugs Market Size by Country (US$ Million), 2027–2032

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Oral Peptide Drugs Product

Table 49. Roche Revenue in Oral Peptide Drugs Business (US$ Million), 2021–2026

Table 50. Roche Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Oral Peptide Drugs Product

Table 54. Novartis Revenue in Oral Peptide Drugs Business (US$ Million), 2021–2026

Table 55. Novartis Recent Development

Table 56. Aurinia Company Details

Table 57. Aurinia Business Overview

Table 58. Aurinia Oral Peptide Drugs Product

Table 59. Aurinia Revenue in Oral Peptide Drugs Business (US$ Million), 2021–2026

Table 60. Aurinia Recent Development

Table 61. Merck & Co Company Details

Table 62. Merck & Co Business Overview

Table 63. Merck & Co Oral Peptide Drugs Product

Table 64. Merck & Co Revenue in Oral Peptide Drugs Business (US$ Million), 2021–2026

Table 65. Merck & Co Recent Development

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

Table 69. Authors List of This Report

List of Figures

Figure 1. Oral Peptide Drugs Picture

Figure 2. Global Oral Peptide Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Oral Peptide Drugs Market Share by Type: 2025 vs 2032

Figure 4. Cyclic Peptides Features

Figure 5. Linear Peptides Features

Figure 6. Global Oral Peptide Drugs Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Oral Peptide Drugs Market Share by Application: 2025 vs 2032

Figure 8. Tumors Case Studies

Figure 9. Kidney Disease Case Studies

Figure 10. Other Case Studies

Figure 11. Oral Peptide Drugs Report Years Considered

Figure 12. Global Oral Peptide Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Oral Peptide Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Oral Peptide Drugs Market Share by Region: 2025 vs 2032

Figure 15. Global Oral Peptide Drugs Market Share by Players in 2025

Figure 16. Global Oral Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Oral Peptide Drugs Revenue in 2025

Figure 18. North America Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Oral Peptide Drugs Market Share by Country (2021–2032)

Figure 20. United States Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Oral Peptide Drugs Market Share by Country (2021–2032)

Figure 24. Germany Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Oral Peptide Drugs Market Share by Region (2021–2032)

Figure 32. China Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Oral Peptide Drugs Market Share by Country (2021–2032)

Figure 40. Mexico Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Oral Peptide Drugs Market Share by Country (2021–2032)

Figure 44. Israel Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Oral Peptide Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Roche Revenue Growth Rate in Oral Peptide Drugs Business (2021–2026)

Figure 48. Novartis Revenue Growth Rate in Oral Peptide Drugs Business (2021–2026)

Figure 49. Aurinia Revenue Growth Rate in Oral Peptide Drugs Business (2021–2026)

Figure 50. Merck & Co Revenue Growth Rate in Oral Peptide Drugs Business (2021–2026)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Peptide Therapy Market Research Report 2025

Global Injection Peptide Drug Market Research Report 2025

Global Oral Peptide Drug Market Research Report 2025

Global Peptide Drugs for Diabetes Market Research Report 2024

Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Proteins and Peptides Market Research Report 2025

Global Peptide based Generics Market Research Report 2024

Global Protein and Peptide Therapeutics Market Research Report 2025

Global Chemical Synthesis Peptide Drugs Market Research Report 2024

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Global Peptide and Oligonucleotide Drugs Market Research Report 2024

Global Oral Peptide Therapeutics Market Research Report 2024

Global Peptide Supplement Market Research Report 2024

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Clinical Peptide Market Research Report 2024

Global Oral Insulin Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions